October 2010 Issue Table Of Contents

Editor’s Note

• What’s With All The Weed?

Feature

• Orphan Drugs: Big Pharma’s Next Act?
• The Challenges Of Bringing A Cannabis-Based Drug To Market

Inside The Industry

• The Development Of Injectable Bioproducts: The Perfect Three-Step Waltz
• Is It Time To Retool To Single-Use?
• Quick Response Manufacturing: Taking The Pharmaceutical Industry Beyond Lean Six Sigma
• M&A And The Pharma Supply Chain: Avoiding Critical Disruptions
• Zinc Fingers Point The Way
• The High Stakes Of Running A Successful Oncology Trial
• Six Insurance Gaps Pharma/Biotech Companies Should Avoid
• Improving Market Access Across Europe
• Building A Culture Of FCPA Compliance

Industry Leader

• Determining Security Capabilities Of Ground Transportation Companies